2018-08-20 - OBSERVABLE Meeting
Date
2018-08-20 20.00 UTC
Zoom Details
Attendees
@Former user (Deleted)
@Farzaneh Ashrafi
@Rob Hausam
@Suzanne Santamaria
@Daniel Karlsson
@Former user (Deleted)
@Former user (Deleted)
Apologies
Objectives
Discuss representation of diagnostic products (to be used as values for susceptibility observables)
Bloodpressure request review
Target observables request review
Discussion items
Item | Description | Owner | Notes | Action |
|
---|---|---|---|---|---|
1 | Welcome & apologies | @Daniel Karlsson |
|
|
|
2 | Conflicts of interest | @Daniel Karlsson |
|
|
|
3 | Previous minutes | @Daniel Karlsson |
|
|
|
4 | Susceptibility | @Suzanne Santamaria @Farzaneh Ashrafi @Daniel Karlsson @Former user (Deleted) |
| @Daniel Karlsson to update the editorial guidelines for "diagnostic substance products" based on the discussion report back at next meeting |
|
5 | Diastolic arterial pressure | @Suzanne Santamaria | "Diastolic arterial pressure - please can you review current content regarding diastolic arterial pressure and add a new concept for Diastolic arterial pressure. There is a concept that is inactive. This would match 72313002|Systolic arterial pressure (observable entity)|, and thus provide the required Observable targets for all GP composite BP readings. There are currently two observable entity concepts for the recording of 271649006 | Systolic blood pressure (observable entity) and 72313002 | Systolic arterial pressure (observable entity) but the diastolic observable entity concept (271650006 | Diastolic blood pressure (observable entity)) has the synonym of 2620223019 | Diastolic arterial pressure. Please can you review this concept and add a new concept for Diastolic arterial pressure? Primary care composite BP readings (of which there are a few billion to be migrated...) are generally recorded against two READ2/CTV3 codes, one for the systolic and one for the diastolic element. These need mapping to SCT observables. The 'obvious' targets of 271649006|Systolic blood pressure (observable entity)| and 271650006|Diastolic blood pressure (observable entity)| are IMHO in fact inappropriate because they're groupers: they subsume, for example, the notions of target BP. This is potentially a problem in querying contexts; I'd rather move the 'random' BP readings further down the taxonomy. A suitable concept already exists under 271649006|Systolic blood pressure (observable entity)|, but the proposed solution requires the other half instating under 271650006|Diastolic blood pressure (observable entity)|. http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2358-04292017000600005 https://www.ncbi.nlm.nih.gov/pubmed/18469640" I reviewed the Vital signs I/E document again ( https://snomed.atlassian.net/wiki/x/j4-OBw) and didn’t find this specifically addressed except the mention of the above description. Some questions I have:
| @Suzanne Santamaria Get back to requesters about preference (submitted question on 20 August following call) @Former user (Deleted) Ask UK for use statistics for the BP observables |
|
6 | Target observables | @Suzanne Santamaria | ...two member countries (US and UK) have requested a series of target observables in the past (2011?). The request was "hidden" in a JIRA ticket rather than both being in CRS so they have not been on our radar. There is a chance they could be added to SNOMED CT if: 1) SI and the US agree to add the content; 2) the precoordination pattern was unblocked (PCP-5 artf223120-Target range/value for <X> (observable entity) is an “unreviewed” and blocking pre-coordination pattern, but could be reviewed shortly). Before I proceed in inquiring about the above, we wanted to seek modeling advice for these type of concepts. Could they be modeled or would they need to be primitives at this point in time? Previous discussions: 2016-10-24--26 - OBSERVABLE Meeting | @Daniel Karlsson Look for additional work done previously |
|
7 | Next meeting | @Daniel Karlsson |
|
@Daniel Karlsson Set up face-to-face meeting page with agenda proposal |
|
8 | AOB | @Daniel Karlsson |
|
|
|
Meeting Files
Previous Meetings
Title | Creator | Modified | |
---|---|---|---|
2016-11-21 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
2020-07-20 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
2020-08-17 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | 7 |
2020-09-21 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
2020-10-19 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
2020-12-14 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
2021-02-08 - OBSERVABLE Meeting | Daniel Karlsson | 2025-Sep-09 | |
E2O meeting 20220825 | Daniel Karlsson | 2022-Aug-25 | |
2022-05-23 - OBSERVABLE Meeting | Daniel Karlsson | 2022-May-24 | |
E2O meeting 20220504 | Daniel Karlsson | 2022-May-05 | |
2022-04-25 - OBSERVABLE Meeting | Daniel Karlsson | 2022-Apr-26 | |
2022-04-06 - OBSERVABLE Face-to-face Meeting | Daniel Karlsson | 2022-Apr-25 |
More Zoom details
Topic: Observables meeting
Time: this is a recurring meeting Meet anytime
Join from PC, Mac, Linux, iOS or Android:
https://snomed.zoom.us/j/992630241
Or Telephone:
Dial:
+46 (0) 8 4468 2488 (SE Toll)
+61 (0) 2 8015 2088 (AU Toll)
+32 (0) 2 588 4188 (BE Toll)
+1 647 558 0588 (CA Toll)
+56 41 256 0288 (CL Toll)
+420 2 2888 2388 (CZ Toll)
+45 89 88 37 88 (DK Toll)
+372 880 1188 (EE Toll)
+852 5808 6088 (HK Toll)
+353 (0) 1 691 7488 (IE Toll)
+972 (0) 3 978 6688 (IL Toll)
+370 5214 1488 (LT Toll)
+60 3 9212 1727 (MY Toll)
+356 2778 1288 (MT Toll)
+31 (0) 20 241 0288 (NL Toll)
+64 (0) 9 801 1188 (NZ Toll)
+64 (0) 4 831 8959 (NZ Toll)
+47 2396 0588 (NO Toll)
+48 22 307 3488 (PL Toll)
+351 308 804 188 (PT Toll)
+65 3158 7288 (SG Toll)
+421 233 056 888 (SK Toll)
+386 1888 8788 (SI Toll)
+34 91 198 0188 (ES Toll)
+41 (0) 31 528 0988 (CH Toll)
+44 (0) 20 3695 0088 (GB Toll)
+1 408 638 0968 (US Toll)
+1 646 876 9923 (US Toll)
+1 669 900 6833 (US Toll)
Meeting ID: 992 630 241
International numbers available: https://snomed.zoom.us/zoomconference?m=AQWV2VqAIGYWMcMapl9CoYjsaj1TVS7K
Copyright © 2025, SNOMED International